ANTOLRX
At AnTolRx they are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies broadly suppress the immune system, inducing side effects that may include life threatening infections and tumors. Thus, there is an unmet clinical need for methods of targeted immune-regulation. Their proprietary drug development approach selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases.
ANTOLRX
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.antolrx.com
Total Employee:
11+
Status:
Active
Contact:
(617)945-8468
Email Addresses:
[email protected]
Total Funding:
4 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Font API Google Tag Manager WordPress Google Analytics SSL By Default Global Site Tag
Similar Organizations
Crown Bioscience
CrownBio is helping provide clarity of action in the fight against cancer and diabetes.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Proclara Biosciences
Proclara is pioneering a new approach to treating neurodegenerative diseases.
Patara Pharma
Patara Pharma operates in the healthcare industry focusing on the biotechnology business.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
VLP Therapeutics
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
JDRF (The Juvenile Diabetes Research Foundation)
JDRF (The Juvenile Diabetes Research Foundation) investment in Series A - AnTolRx
Orion Healthcare Equity Partners
Orion Healthcare Equity Partners investment in Series A - AnTolRx
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - AnTolRx
Official Site Inspections
http://www.antolrx.com Semrush global rank: 9.08 M Semrush visits lastest month: 445
- Host name: staging.seniorlivinginc.com
- IP address: 66.94.40.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AnTolRx"
AnTolRx - Crunchbase Company Profile & Funding
At AnTolRx they are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune …See details»
AnTolRx Company Profile 2024: Valuation, Funding & Investors
AnTolRx General Information Description. Developer of novel nanoformulation-based therapies designed to treat autoimmune diseases. The company's drug development approach …See details»
Team - ANTOLRX
AnTolRx is led by an experienced and knowledgeable team of scientists, advisors, board members and partners dedicated to developing new therapeutics and advancing the field of immunotherapy. AnTolRx was founded based on …See details»
AnTolRx, Inc. Overview | SignalHire Company Profile
AnTolRx, Inc. is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. ...See details»
AnTolRx, Inc. - Company Profile & Staff Directory - ContactOut
Discover AnTolRx, Inc. company details, including staff directory, contact information, and industry insights. Explore alternatives, competitors, and frequently asked questions to get …See details»
Antolrx, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Antolrx, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Immune System Diseases, Endocrinology and Metabolic Disease, Nervous …See details»
Antolrx - Overview, News & Similar companies | ZoomInfo.com
Mar 4, 2019 Who is Antolrx. AnTolRx is a Cambridge, Mass.-based research and development biotechnology company focused on immune tolerance with active programs in Type 1 Diabe …See details»
AnTolRx Company Profile - Office Locations, Competitors ... - Craft
AnTolRx is a biotech company focused on the treatment of autoimmune diseases. Its lead programs address unmet needs in the fields of type 1 diabetes, rheumatoid arthritis, …See details»
Antolrx, Inc. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AntolRx, Inc. of Belmont, MA. Get the latest business insights from Dun & Bradstreet.See details»
Our Vision | ANTOLRX
At AnTolRx we are approaching the treatment of autoimmune diseases differently–through the development of novel nanoformulation-based therapies to promote antigen-specific immune …See details»
AnTolRx, Inc. Announces Series A Equity - Pfizer
CAMBRIDGE, Mass., September 8, 2016—AnTolRx, Inc. announced today that it has signed a Series A funding agreement with Pfizer Inc. (NYSE: PFE), Orion Equity Partners LLC and …See details»
AnTolRx Company Profile: Overview and Full News Analysis
AnTolRx is a biopharmaceutical company based in Massachusetts that is focused on revolutionizing the treatment of autoimmune diseases through their innovative products and …See details»
AnTolRx - Products, Competitors, Financials, Employees, …
AnTolRx, Diabeloop, IPaDiC, Encellin & POLTREG develop 5 top solutions to watch out for. Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups …See details»
AnTolRx - Funding, Financials, Valuation & Investors - Crunchbase
AnTolRx is funded by 3 investors. JDRF (The Juvenile Diabetes Research Foundation) and Orion Healthcare Equity Partners are the most recent investors. AnTolRx has a post-money …See details»
AnTolRx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. AnTolRx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF …
CAMBRIDGE, Mass., September 8, 2016—AnTolRx, Inc. announced today that it has signed a Series A funding agreement with Pfizer Inc. (NYSE: PFE), Orion Equity Partners LLC and …See details»
Contact | ANTOLRX
ANTOLRX, INC. One Kendall Square Building 1400 West, Suite 14303 Cambridge, MA 02139See details»
News - ANTOLRX
Oct 29, 2019 CAMBRIDGE, Mass., September 8, 2016—AnTolRx, Inc. announced today that it has signed a Series A funding agreement with Pfizer Inc. (NYSE: PFE), Orion Equity Partners …See details»
Pipeline - ANTOLRX
We are rapidly advancing a potential therapy for the treatment of Type 1 Diabetes and are advancing pre-clinical programs in a number of other auto-immune related diseases, including …See details»